YOU’RE INVITED TO AN EXCLUSIVE WEBINAR:
Biosimilars in Focus for Retina Practices
Please join us on April 26, 2023 | 6:00 p.m. CT
More retina biosimilars are entering the pipeline, including last year’s first interchangeable product across all five indications. Don’t miss this upcoming opportunity to join our retina-focused discussion on Wednesday, April 26 to gain a better understanding of the foundational science behind biosimilars and the evolving payer landscape.
Hear from clinical and business experts:
Tim Ho, PharmD, BCOP
Regional Clinical Consultant, McKesson
Christine Kern, MBA
Regional Director Managed Care Contracting, McKesson
Key takeaways:
- Understand the difference between reference drugs and biosimilars as well as the FDA’s position and guidelines
- Learn about the clinical efficacy of biosimilar therapies
- Address reimbursement hurdles
- Learn how to develop a payer strategy
- Prepare for biosimilars at your retina practice with confidence